
Sign up to save your podcasts
Or


Breakthroughs in artificial intelligence and neurotechnology are revolutionizing healthcare, enabling people with debilitating diseases to communicate in ways previously impossible. Implantable devices like the Stentrode, developed by Synchron, can translate brain signals into physical actions, giving patients like Rodney, who has ALS, the ability to type using only his thoughts. As the neurotech market grows, projected to reach $55 billion by 2032, companies like Meta and Apple are investing in non-invasive devices to decode thoughts and perceptions, but concerns over mental privacy are driving calls for regulation and policy change.
By Dr. Tony Hoang4.6
99 ratings
Breakthroughs in artificial intelligence and neurotechnology are revolutionizing healthcare, enabling people with debilitating diseases to communicate in ways previously impossible. Implantable devices like the Stentrode, developed by Synchron, can translate brain signals into physical actions, giving patients like Rodney, who has ALS, the ability to type using only his thoughts. As the neurotech market grows, projected to reach $55 billion by 2032, companies like Meta and Apple are investing in non-invasive devices to decode thoughts and perceptions, but concerns over mental privacy are driving calls for regulation and policy change.

91,142 Listeners

32,147 Listeners

229,051 Listeners

1,095 Listeners

340 Listeners

56,472 Listeners

153 Listeners

8,889 Listeners

2,040 Listeners

9,909 Listeners

70 Listeners

1,864 Listeners

80 Listeners

268 Listeners

4,233 Listeners